Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)

Technology appraisal
Reference number: TA570
Published: 20 March 2019

History

Documents created during the development process.

Invitation to participate

Final scope (PDF 239 KB)

Published:

03 January 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 127 KB)

Published:

03 January 2018
Equality impact assessment (Scoping) (PDF 172 KB)

Published:

03 January 2018
Final matrix (PDF 263 KB)

Published:

03 January 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 287 KB)

Published:

19 July 2017
Draft matrix post referral (PDF 263 KB)

Published:

19 July 2017